BPG is committed to discovery and dissemination of knowledge
Brief Article
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2014; 20(9): 2383-2391
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2383
Figure 3
Figure 3 Peptide YY cell densities in the ileum of controls and in all patients with irritable bowel syndrome, patients with diarrhea as the predominant symptom, patients with both diarrhea and constipation, and patients with constipation as the predominant symptom patients. aP < 0.05, bP < 0.01 vs controls. PYY: Peptide YY; IBS-total: All patients with irritable bowel syndrome; IBS-D: Patients with diarrhea as the predominant symptom; IBS-M: Patients with both diarrhea and constipation; IBS-C: Patients with constipation as the predominant symptom.


Write to the Help Desk